Federal award (DEFINITIVE CONTRACT, fiscal year 2023)
Recipient: SPERO THERAPEUTICS, INC.
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2018-07-12 to 2025-12-31
Current total value of award: $43372809
Description: MODIFICATION P00015  THE PURPOSE OF THIS BILATERAL MODIFICATION IS TO: A) INCREASE THE US GOVERNMENT FUNDING FOR CLIN 0005 OPTION 4 FROM $12,498,467 BY $11,697,110 TO $24,195,577 AND THE SPERO COST SHARE FROM $63,204,595 BY $14,683,133 TO $77,887,